| Literature DB >> 34635724 |
Pablo Vera1,2, Alejandro Lorente3, Jesús Burgos4, Pablo Palacios5, Luis M Antón-Rodrigálvarez3, Rocio Tamariz6, Carlos Barrios7, Rafael Lorente8.
Abstract
The aim of this study was to analyze the impact of surgical correction of the thoracic deformity on the cardiorespiratory function of patients with moderate-severe Scheuermann's hyperkyphosis (SK). A series of 23 adolescents with SK who underwent surgery through an only posterior approach using all pedicle screw constructs were included in the study. Cardiorespiratory parameters were measured during a maximal exercise tolerance test before and 2 years after surgery. Heart rate, oxygen saturation (SatO2), maximum oxygen uptake (VO2 max), ventilatory capacity at maximal exercise (VEmax), and energy costs were recorded. There were statistically significant differences in the forced vital capacity (FVC) (P < 0.05), total VO2max (ml/min) (P < 0.01), maximum expired volume (VEmax) per minute (P < 0.01) and cardiovascular efficiency (HR/VO2 ratio) (P < 0.05). None of these changes were clinically relevant. There were no changes in the VO2max per kg of body mass. The magnitude of the kyphosis correction did not correlate with the change in normalized VO2max or VEmax. In conclusion, patients with moderate-severe SK improve their baseline respiratory limitations and the tolerance to maximum exercise 2 years after surgery. However, the slight cardiorespiratory functional improvements should not necessarily be attributed to the surgery, and could also be caused solely by the residual growth of the lungs and thorax. Furthermore, respiratory functional changes are under thresholds considered as clinically relevant.Entities:
Mesh:
Year: 2021 PMID: 34635724 PMCID: PMC8505618 DOI: 10.1038/s41598-021-99674-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Anthropometric, and thoracic kyphotic curve characteristics of the SK patients before and after surgery.
| Preoperative | 2-years Postop | Wilcoxon Rank test | ||
|---|---|---|---|---|
| Median ± IQR | Median ± IQR | Z | ||
| Age (years) | 14 ± 1 | 16. ± 1 | − 4.796 | 0.000* |
| Weight (kg) | 63 ± 14 | 65 ± 12 | − 3.475 | 0.001* |
| Height (cm) | 162 ± 5 | 168 ± 5 | − 4.119 | 0.000* |
| BMI (kg/m2) | 23 ± 4.8 | 23.3 ± 4.7 | − 0.243 | 0.808 |
| T2-T12 Kyphosis (ºCobb) | 77 ± 7 | 45 ± 5 | − 4.204 | 0.000* |
IQR: Interquartile range; *P < 0.01.
Figure 1Frequency and involved levels of the kyphotic curves.
Results of the tolerance exercise test in patients with corrected and uncorrected Scheuermann thoracic hyperkyphosis.
| Exercise Tolerance Test | Before Surgery vs Corrected Wilcoxon Rank test | |||
|---|---|---|---|---|
| Before Surgery | Corrected Kyphosis | |||
| Median ± IQR | Median ± IQR | Z | ||
| HR basal (bpm) | 115.0 ± 24.5 | 115.0 ± 21.5 | − 0.891 | 0.373 |
| HR max (bpm) | 184.5 ± 10.2 | 184.5 ± 10.2 | − 1.598 | 0.110 |
| Syst. BP (mmHg) | 120.0 ± 6.2 | 120.0 ± 20.0 | − 0.973 | 0.330 |
| Syst. BP max (mmHg) | 162.5 ± 30.0 | 160.0 ± 20.0 | − 2.023 | 0.043* |
| Sat O2 initial (%) | 98.0 ± 2.0 | 98.0 ± 2.2 | − 1.204 | 0.229 |
| Sat O2 final (%) | 93.0 ± 3.2 | 93.0 ± 3.0 | − 1.685 | 0.092 |
| VO2 max (ml/min) | 2.540 ± 126 | 2.860 ± 125 | − 2.618 | 0.009** |
| VO2 max/kg | 35.0 ± 9.8 | 35.0 ± 10.0 | − 1.141 | 0.370 |
| VCO2 (ml/min) | 3340 ± 151 | 3200 ± 139 | − 1.329 | 0.254 |
| RER (VCO2/VO2) | 1.26 ± 0.15 | 1.28 ± 0.12 | − 1.236 | 0.216 |
| FVC | 3.8 ± 1.2 | 4.0 ± 1.0 | − 1.978 | 0.048* |
| FVC (% of predicted) | 67.0 ± 13.5 | 69.0 ± 13.2 | − 3.157 | 0.002** |
| VE (L/min) | 61.9 ± 30.0 | 62.5 ± 30.0 | − 2.282 | 0.010* |
| Respiratory (VE/VCO2) | 19.6 ± 4.8 | 20.1 ± 3.3 | − 1.034 | 0.301 |
| Cardiovascular (HR/VO2) | 81.2 ± 32.6 | 71.6 ± 36.6 | − 2.464 | 0.014* |
| Test duration (min) | 9.2 ± 1.4 | 9.3 ± 1.4 | − 2.971 | 0.003* |
| METS | 10.2 ± 2.9 | 9.9 ± 3.2 | − 1.553 | 0.121 |
IQR: Interquartile range HR: heart rate; BP: blood pressure; Sat O2: saturation O2; Pu02: pulse of oxygen; VO2 max: oxygen uptake at maximal exercise; VC02: carbon dioxide output; VE/VCO2: expiratory volume and carbon dioxide output ratio; RER: respiratory exchange ratio; VE, ventilation; VE/VO2: ventilatory efficiency; HR/VO2: cardiovascular efficiency; mmHg: millimetres of mercury; % of predicted: percentage of predicted FVC according to age, sex, height, mass and ethnicity; L/min: litres per minute); METS: metabolic equivalents of tasks.
*P < 0.05.
Figure 2Changes in VO2max (ml/min/kg) and VE (L/min) after surgical correction of the hyperkyphosis as compared to preoperative data.
Figure 3Correlation between VO2max y VEmax in the CPET before surgery (r = 0.725; P < 0.001) and 2-year after surgery (r = 0.699; P < 0.001).
Figure 4Magnitude of the thoracic kyphotic, maximal aerobic power (VO2max in ml/min/kg) and maximal ventilation (VEmax in L/min) in SK patients before and 2-year after surgery.